Roles for Gp96 in pro- and anti-tumour responses have been identified, and it has, for example, been found to promote glioma oncogenesis and progression, while tumour-derived Gp96 has been assessed as a candidate for tumour vaccination [105]. The gene discussed is HSP90B1; the disease is central nervous system cancer.